ASSESSMENT OF THE QUALITY OF LIFE OF PATIENTS WITH THE JUVENILE IDIOPATHIC ARTHRITIS TREATED BY THE ETANERCEPT

ASSESSMENT OF THE QUALITY OF LIFE OF PATIENTS WITH THE JUVENILE IDIOPATHIC ARTHRITIS TREATED BY THE ETANERCEPT

Aim: To assess the influence of the genetically engineered biologic drug etanercept on the quality of life of patients with juvenile idiopathic arthritis (JIA). Patients and methods: The research included 85 children with poly-and oligoarticular variant of the JIA at the age of 5 (2; 17) years. The...

Full description

Saved in:
Bibliographic Details
Main Authors: A. N. Fetisova, E. I. Alexeeva, T. M. Bzarova, S. I. Valieva, V. V. Chernikov, I. V. Vinyarskaya, R. V. Denisova, K. B. Isaeva, E. G. Chistyakova, Т. V. Sleptsova, N. I. Taibulatov
Format: Article
Language:English
Published: "Paediatrician" Publishers LLC 2014-07-01
Series:Вопросы современной педиатрии
Subjects:
children
juvenile idiopathic arthritis
etanercept
quality of life
health utilities index mark 3
Online Access:https://vsp.spr-journal.ru/jour/article/view/164
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://vsp.spr-journal.ru/jour/article/view/164

Similar Items